Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher this morning reported revenues for its second quarter grew 24 percent year over year, as sales in its Medical Technologies segment grew 31 percent for the period, helped along by its recent purchases of AB Sciex and Molecular Devices.

For the three months ended July 2, revenues grew to $3.31 billion from $2.67 billion in the year-ago period.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.

In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.